• Home
• Latest News
• Latest Deals
• Report Store
• Contact Us

Sign up for our FREE Weekly Genito Urinary System and Sex Hormones ResearchViews Update.

Please enter your email address below*:

""  Click Here

Free Research Papers Latest Genito Urinary System Reports Latest Genito Urinary System Deals Ardea Biosciences Prices Public Offering Of Common Stock For $145 Million Published: Jan 31 2012 Repros Therapeutics Completes Private Placement Of Shares For $11.1 Million Published: Jan 27 2012 OptMed Raises $0.32 Million In Venture Financing Published: Jan 23 2012 Antares Pharma Enters Into Licensing Agreement With Daewoong Pharma For Oxybutynin Gel Published: Jan 17 2012 Arena Pharma Announces Registered Direct Offering Of Common Stock For $16.5 Million Published: Jan 11 2012 Latest Genito Urinary System News Prometheus Laboratories Appoints Anthony Yost As Senior Vice President And Chief Commercial Officer Date of story: Feb 03 2012 Dr. Reddy’s Reports Revenue Of $522m In Q3 Fiscal 2012 Date of story: Feb 03 2012 Dynavax Reports On Heplisav Pre-BLA Meeting With FDA Date of story: Feb 02 2012 AstraZeneca Reports Revenue Of $8.7 Billion In Q4 2011 Date of story: Feb 02 2012 Merck Reports Net Sales Of $12.3 Billion In Q4 2011 Date of story: Feb 02 2012 Latest Genito Urinary System and Sex Hormones Reports Interstitial Cystitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 By: GlobalData, Published: Jan-2012 Overactive Bladder Therapeutics - Pipeline Assessment and Market Forecasts to 2019 By: GlobalData, Published: Jan-2012 Polycystic Kidney Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2019 By: GlobalData, Published: Jan-2012 Proteinuria - Pipeline Review, H2 2011 By: Global Markets Direct, Published: Nov-2011 Urinary Incontinence (UI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 By: GlobalData, Published: Nov-2011